Informing Patients about Biosimilar Medicines: The Role of European Patient Associations.

ABSTRACT: Biosimilar medicines support the sustainability of national healthcare systems, by reducing costs of biological therapies through increased competition. However, their adoption into clinical practice largely depends on the acceptance of healthcare providers and patients. Patients are different from health care professionals (HCPs), who are informing themselves professionally. For patients, the biosimilar debate only becomes actual when they are confronted with disease and drug choices. This paper provides a literature review on how patients are and should be informed about biosimilars, searching in scientific databases (i.e., Medline, Embase). Several large surveys have shown a lack of knowledge and trust in biosimilars among European patients in recent years. This review identified five m

SUBMITTER: Vandenplas Y 

PROVIDER: S-EPMC7913743 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature